Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
191.6 USD | +2.71% |
|
-10.17% | +11.37% |
06-25 | Oppenheimer Downgrades ResMed to Market Perform From Outperform | MT |
06-24 | Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.37% | 27.4B | |
+3.77% | 213B | |
+8.83% | 188B | |
+31.94% | 157B | |
+33.19% | 113B | |
+5.25% | 64.85B | |
+22.41% | 55.17B | |
+1.34% | 49.1B | |
-5.92% | 38.83B | |
+1.94% | 35.6B |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- Transcript : ResMed Inc., Q2 2019 Earnings Call, Jan 24, 2019